PMC:7795856 / 22499-22656 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"389","span":{"begin":36,"end":39},"obj":"Gene"},{"id":"394","span":{"begin":86,"end":90},"obj":"Chemical"},{"id":"399","span":{"begin":49,"end":54},"obj":"Disease"}],"attributes":[{"id":"A389","pred":"tao:has_database_id","subj":"389","obj":"Gene:134864"},{"id":"A394","pred":"tao:has_database_id","subj":"394","obj":"MESH:C046274"},{"id":"A399","pred":"tao:has_database_id","subj":"399","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In fact, fusion of the short-acting Tα1 with the tumor-targeting iRGD peptide using a Gly4 linker has recently demonstrated enhanced antitumor activity [50]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T22","span":{"begin":49,"end":54},"obj":"Phenotype"}],"attributes":[{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"In fact, fusion of the short-acting Tα1 with the tumor-targeting iRGD peptide using a Gly4 linker has recently demonstrated enhanced antitumor activity [50]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T127","span":{"begin":0,"end":157},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In fact, fusion of the short-acting Tα1 with the tumor-targeting iRGD peptide using a Gly4 linker has recently demonstrated enhanced antitumor activity [50]."}